Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone. (Q33148910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Kerry E Culm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jerold S Harmatz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

David J Greenblatt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lisa L von Moltke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Brian W Granda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Steven M Fogelman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gengsheng Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jennifer A Graf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Polyxane Mertzanis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Susan Byron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Johanna P Daily

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Clinical Pharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

414-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

Use of psychotropic drugs in patients with HIV infection

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Psychotropic drug prescribing for hospitalized patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Depressive symptoms over the course of HIV infection before AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Depression in patients with HIV and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Significant interactions with new antiretrovirals and psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

In vitro and in vivo drug interactions involving human CYP3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

The emerging role of cytochrome P450 3A in psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Trazodone hydrochloride: a wide spectrum antidepressant with a unique pharmacological profile. A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Human CYP2D6 and metabolism of m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Interactions among drugs for HIV and opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Dual protease inhibitor therapy in HIV-infected patients: pharmacologic rationale and clinical benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Lopinavir-Ritonavir: a new protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Human drug metabolism and the cytochromes P450: application and relevance of in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Clinical pharmacokinetics of alprazolam. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

P-glycoprotein interactions of nefazodone and trazodone in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Ritonavir's role in reducing fentanyl clearance and prolonging its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Alprazolam-ritonavir interaction: implications for product labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Analysis of Zolpidem in Human Plasma by High-Performance Liquid Chromatography with Fluorescence Detection: Application to Single-Dose Pharmacokinetic Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Inhibition and induction of cytochrome P450 and the clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Trazodone kinetics: effect of age, gender, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Mechanism-based enzyme inactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251864

21 January 2018

Identifiers

DOI

10.1177/0091270003251864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json

release_k4wp4ubjlrb2xmrskzzxowpexy

3 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k4wp4ubjlrb2xmrskzzxowpexy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12723462%20AND%20SRC:MED&resulttype=core&format=json